News
Firebrick Pharma is a pharmaceutical innovator focused on developing and commercializing novel formulations and uses of povidone-iodine (PVP-I). The company has developed Nasodine® Nasal Spray (0 ...
BPL-003 showed “robust” efficacy data in treatment-resistant depression, according to analysts from Jefferies, who noted that ...
Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.
The FTC sued Xlear after it marketed its spray as a covid preventative. The Trump administration dropped the suit, but the ...
Adults on dupilumab for severe chronic rhinosinusitis with nasal polyps had better outcomes than those who used omalizumab, ...
The arrival of nasal adrenaline - an innovation in the treatment of anaphylaxis This symposium presented the EURneffy ® nasal adrenaline spray as a new treatment option designed to address the unmet ...
ARS Pharma has claimed FDA approval for its epinephrine nasal spray neffy, becoming the first needle-free alternative to EpiPen-style autoinjectors for serious allergic reactions. The green light ...
STS101 nasal powder, DHE, delivers fast, lasting relief from cardinal migraine symptoms, including photophobia, phonophobia, ...
The FDA expanded the approval of the SONU Band to include the treatment of patients aged 12 years and older with moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results